Aperio Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | $6.54M | Buy |
89,365
+5,888
| +7% | +$431K | 0.02% | 717 |
|
2020
Q3 | $6.49M | Buy |
83,477
+19,086
| +30% | +$1.48M | 0.02% | 649 |
|
2020
Q2 | $3.58M | Sell |
64,391
-6,136
| -9% | -$341K | 0.01% | 861 |
|
2020
Q1 | $2.09M | Buy |
70,527
+27,552
| +64% | +$816K | 0.01% | 998 |
|
2019
Q4 | $1.56M | Buy |
42,975
+40
| +0.1% | +$1.45K | 0.01% | 1206 |
|
2019
Q3 | $1.17M | Buy |
42,935
+6,868
| +19% | +$187K | ﹤0.01% | 1316 |
|
2019
Q2 | $868K | Buy |
36,067
+676
| +2% | +$16.3K | ﹤0.01% | 1473 |
|
2019
Q1 | $935K | Buy |
35,391
+9,743
| +38% | +$257K | ﹤0.01% | 1398 |
|
2018
Q4 | $501K | Buy |
25,648
+7,360
| +40% | +$144K | ﹤0.01% | 1677 |
|
2018
Q3 | $358K | Buy |
18,288
+1,873
| +11% | +$36.7K | ﹤0.01% | 1934 |
|
2018
Q2 | $272K | Buy |
+16,415
| New | +$272K | ﹤0.01% | 2038 |
|